Innovative Stroke Risk Calculator Enhances Prediction for Atrial Fibrillation Patients
A groundbreaking blood test-based risk calculator improves prediction accuracy for stroke in atrial fibrillation patients, aiding personalized treatment decisions.
Researchers from the University of North Carolina at Chapel Hill and the University of Vermont have introduced a new, more precise tool to evaluate stroke risk among individuals with atrial fibrillation (A-Fib), a prevalent heart rhythm disorder affecting over 10.5 million Americans and a leading cause of stroke. Published in the renowned Journal of Thrombosis and Haemostasis, their studies reveal that integrating blood test data into existing risk assessment models significantly improves predictive accuracy.
Atrial fibrillation causes the heart’s top chambers to quiver irregularly, slowing blood flow and increasing the likelihood of blood clot formation. These clots can travel to the brain, triggering strokes. While blood thinning medications, or anticoagulants, are effective in reducing this risk, they carry potential side effects, especially bleeding complications. Thus, accurately identifying patients who truly need these medications is crucial.
Current risk prediction primarily relies on the CHA2DS2-VASc score, which considers age, gender, and medical history. However, this method overlooks key factors like heart dysfunction, inflammation, and clotting tendencies. To address this gap, the researchers developed the CHA2DS2-VASc-Biomarkers score, which incorporates blood test results to refine risk prediction.
In two comprehensive studies involving over 3,100 participants followed for up to 13 years, scientists identified two blood biomarkers that enhance the prediction of stroke beyond traditional scores. These findings lead to a new scoring system capable of helping doctors decide who may benefit most from anticoagulant therapy.
Although the improved calculator is not yet available for clinical use, it promises to reduce unnecessary medication in low-risk patients and ensure high-risk individuals receive appropriate preventive treatment, potentially saving lives and reducing healthcare costs.
Source: https://medicalxpress.com/news/2025-10-physicians-atrial-fibrillation-patients.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Persistent Use of Unnecessary Cancer Screenings Despite Updated Guidelines, New Study Reveals
A new study reveals that unnecessary cancer screenings persist for years after guidelines advise against them, leading to overdiagnosis and increased healthcare costs. The research emphasizes the need for better implementation of evidence-based practices.
Understanding Normal Pressure Hydrocephalus: Insights from Billy Joel's Diagnosis
Learn about normal pressure hydrocephalus, its symptoms, causes, and treatments, with insights from Billy Joel's recent diagnosis and treatment at UVA Health.
Study Finds Parental Education Alone Insufficient to Combat Childhood Obesity
Research shows that parental education alone is not enough to prevent childhood obesity; societal policies are essential for effective intervention and healthier futures for children.